|
|
4/08/25
|
In a recent life science lease in Seattle, UW Medicine's Institute for Protein Design (IPD) inked a deal for 31.8k sf of space at 330 Yale, a 211.6k sf, Class A life science facility in the city’s South Lake Union area. The Institute will occupy the entire third floor of the property, which can also accommodate future growth with move-in ready lab space on the second floor, if needed.
Photo: Mark Griffith Photography |
 |
|
The IPD, led by newly minted Nobel Laureate David Baker, is the world’s leading center for advancing protein design. From life-saving vaccines to sustainable materials, IPD scientists are pioneering entirely new proteins that address challenges in medicine, technology and sustainability.
CBRE’s Paul Carr, Marcus Yamamoto and Katie Smith represented the owner, 330 Yale Owner LLC, a subsidiary of KKR-managed accounts. The property is managed by Lincoln Property Company.
After taking ownership of the property last year, 330 Yale Owner LLC has since invested in new amenities, including a large 80+ person divisible conference room, rooftop event space and three move-in ready lab suites that will be completed by Q3 2025.
Leasing activity in the Seattle life science market has gained strong momentum with increased tenant interest from both established and start-up companies in Q4 2024, according to CBRE Research.
|
|
 Return to the Archive page
|
|
|
|
|
Printer-friendly Version
Email an Associate
